Get the Stockscreener App
10.20
0.00%
0.00
After Hours:
10.19
-0.010
-0.10%
Drugs Made In America Acquisition Ii Corp stock is traded at $10.20, with a volume of 100.75K.
It is up +0.00% in the last 24 hours and up +0.20% over the past month.
Drugs Made In America Acquisition II Corp is a blank check Company.
See More
Previous Close:
$10.20
Open:
$10.205
24h Volume:
100.75K
Relative Volume:
0.39
Market Cap:
$649.74M
Revenue:
Net Income/Loss:
$8.58M
P/E Ratio:
76.12
EPS:
0.134
Net Cash Flow:
$-1.11M
1W Performance:
+0.10%
1M Performance:
+0.20%
6M Performance:
+1.80%
1Y Performance:
+0.00%
1-Day Range:
$10.20
$10.21
1-Week Range:
$10.18
$10.21
52-Week Range:
$9.86
$10.33
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
Name
Drugs Made In America Acquisition Ii Corp
Sector
Industry
Phone
954-870-3104
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs VYLR, EVAC, BCSS, CEPF
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.20 | 649.74M | 0 | 8.58M | -1.11M | 0.134 |
VYLR
Vylor Inc.
|
72.40 | 48.31B | 0 | 0 | 0 | 0.00 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.36 | 605.52M | 0 | 12.80M | -714.00K | 0.2184 |
BCSS
Bain Capital Gss Investment Corp
|
10.23 | 597.72M | 0 | 8.29M | -686.50K | 0.142 |
CEPF
Cantor Equity Partners Iv Inc
|
10.32 | 589.79M | 0 | 10.29M | -337.90K | 0.1801 |
Drugs Made In America Acquisition Ii Corp Stock (DMII) Latest News
Shell Companies Stock Performance - Yahoo Finance
Drugs Made In America Acquisition updates merger terms with Power Analytics Global - Investing.com Nigeria
Form 8K Drugs Made In America Acquisition Corp Unit For: 21 October - Investing.com Nigeria
Form 4 DRUGS MADE IN AMERICA ACQUISITION CORP. For: 21 October - Investing.com Australia
Drugs Made In America Acquisition updates merger terms with Power Analytics Global - Investing.com
Silence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, Germany - BioSpace
GIX Stock Price, Quote & News - Syfe
APXT Stock Price, Quote & News - Syfe
Andretti Acquisition II (POLE) Stock Price, News & Analysis - Stock Titan
Drugs Made In America Acquisition II Corp (DMII) Trades Flat at $10.19 as Shares Hold Near Trust ValueIV Spike - https://www.siam.in/
DMII 8-K & SEC Filings - Yahoo Finance Australia
Drugs Made In America Acquisition (DMAA) Stock Price, News & Analysis - Stock Titan
DMAA Stock Holds Near $10.89 as Acquisition Corp. Trades in Tight BandOutside Reversal - https://www.dars.gov.et/
DMAA Stock Holds Near $10.89 as Acquisition Corp. Trades in Tight BandSkew Index - https://www.siam.in/
DMAA Stock Holds Near $10.89 as Acquisition Corp. Trades in Tight BandRip Sell Trade - www.dars.gov.et
DMIIU Holds Steady at $10.20 as Drugs Made In America Acquisition II Unit Trades FlatBreakout Stock Alerts - https://www.dars.gov.et/
DMIIU Holds Steady at $10.20 as Drugs Made In America Acquisition II Unit Trades FlatVolatility Breakout Picks - https://www.siam.in/
HVMC Stock Price, Quote & News - Syfe
Drugs (DMII) Stock Alert: Dead Money at $10.16 — Or Is It? 2026-09-17Break of Structure - dars.gov.et
Drugs (DMII) Stock Alert: Dead Money at $10.16 — Or Is It? 2026-09-17Spring Pattern - dars.gov.et
Drugs Made In America Restructures Merger with PAGC - The Globe and Mail
Inside the $2.85B all-stock deal for DMAA (NASDAQ: DMAA) - Stock Titan
DMII 8-K & SEC Filings - Yahoo Finance Australia
EVOX Stock Price, Quote & News - Syfe
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer - The Manila Times
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeQuality ETF - careplusvn.com
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeETF Inflow Streak - www.dars.gov.et
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq® - PR Newswire
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat
Drugs (DMIIU) Momentum: Ends Little Changed at $10.20 in the Latest Reading; Immediate View: the Supplied Trading Band Runs From $9.69 to $10.71 under the Current SnapshotMomentum Breakout Ideas - siam.in
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingProfitability Factor - careplusvn.com
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionPCR Divergence - careplusvn.com
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionBuyback Factor - dars.gov.et
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionEarnings Miss Risk - www.dars.gov.et
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingRVOL Breakout - dars.gov.et
Drugs (DMIIR) Daily Review: Closes with Little Net Change at $0.10 in Latest Trading; Level-Based View: the Current Price Sits Inside the Supplied Technical Range at the CloseMerger Arbitrage - Vinanet
DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et
DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationDark Pool Sentiment - dars.gov.et
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - vinanet.vn
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - vinanet.vn
Drugs Made In America Acquisition Ii Corp Stock (DMII) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):